跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,712 条关于
“AB2 Bio Ltd.”
全部
16,712
临床试验
5,582
药物
2,901
机构
4,519
资讯
3,710
上个月
Nippon Shinyaku Exercises Option for AB2 Bio's Tadekinig Alfa, Securing U.S. Commercialization Rights for Rare Autoinflammatory Diseases
上个月
Nippon Shinyaku Exercises $30 Million U.S. Commercialization Option for AB2 Bio's Tadekinig Alfa in Ultra-Rare Pediatric Hyperinflammatory Syndrome
去年
AB2 Bio and Nippon Shinyaku Strike $686M Deal for Rare Disease Drug Tadekinig Alfa
去年
PromarkerEso Blood Test Shows 94% Accuracy in Esophageal Cancer Detection
2年前
BioLineRx's APHEXDA Gains Momentum in Stem Cell Mobilization for Multiple Myeloma
2年前
Epsilogen Completes Series B Expansion to Advance IgE Antibody Therapy for Ovarian Cancer
2年前
SciSparc Advances Cannabinoid-Based Therapies for CNS Disorders, Including Autism
去年
Biohaven's Pipeline Advances Drive Optimistic Outlook for 2025
去年
Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease
3个月前
Novartis India Ltd Hits All-Time High Before 10.71% Weekly Correction Amid Profit-Taking
第 1 页,共 371 页
上一页
下一页